Results 201 to 210 of about 232,769 (310)

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis. [PDF]

open access: yesJ Exp Med
Gervais A   +35 more
europepmc   +1 more source

Evolution and Diversity in Human Herpes Simplex Virus Genomes

open access: yesJournal of Virology, 2013
Moriah L. Szpara   +8 more
semanticscholar   +1 more source

New Insights Into Factors Shaping CMV‐Specific T‐Cell Polyfunctionality After Hematopoietic Cell Transplantation

open access: yesAmerican Journal of Hematology, Volume 101, Issue 2, Page 255-268, February 2026.
ABSTRACT Polyfunctional cytomegalovirus (CMV)‐specific T cells are critical for antiviral immunity in allogeneic hematopoietic cell transplantation (HCT) recipients. However, gaps remain in managing refractory CMV and optimizing virus‐specific cellular therapy (VST).
Alicja Sadowska‐Klasa   +9 more
wiley   +1 more source

Camptothecin, a topoisomerase I inhibitor, impedes productive herpes simplex virus type 1 infection

open access: diamond
Joseph R. Heath   +4 more
openalex   +1 more source

Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy